Document:

Exhibit 10.1 

HC Innovations, Inc. 

November 26, 2008 

Binding Term Sheet

Senior Secured Notes

	Amount: 	
         Extension
      of maturity of US$8M existing senior secured notes (the “Notes”)
      to include accrued interest and unpaid fees (if any), plus funding of approximately $250,000
      to repay existing bank indebtedness (as set forth in “Basic Terms
    and Conditions (i)” below). 

	 	 
	
Issuer:  	
     HC Innovations, Inc. (“HCNV”)  
	 	 
	
Guarantors:  	
     All subsidiaries of HCNV.  
	 	 
	
Holders:  	
     Senior secured lenders (“Holders”).  
	 	 
	Initial Closing:	
         On
      or before December 19, 2008. Consummation of the transactions contemplated
      by this Term Sheet will be subject to negotiation, execution and delivery
    of mutually acceptable definitive documentation. 

	 	 
	Ranking: 	
         First
      ranking security interest over all the assets of HCNV and each of its subsidiaries.
      Security shall remain in place until all Notes are converted or are repaid
      in full. The Holders have requested that HCNV's unsecured indebtedness
      (other than ordinary course trade payables) be made junior and subordinate
      in right of payment to the Notes. Representatives of HCNV and the Holders
      will meet with representatives of the unsecured indebtedness to attempt
      to negotiate subordination or other arrangements satisfactory to all parties.a The
        definitive documents will contain a representation from HCNV as to accuracy
        and completeness of the schedule of secured and unsecured indebtedness
    previously supplied to the Holders. 

	 	 
	Extension: 	      In
        order to accommodate the transaction which is contemplated in that certain
        letter of interest that was submitted to HCNV on November 11, 2008 and
        provided to the Holders, or such third party who makes an offer which
        would provide for the mandatory repayment in full of the Holders and
        which the Board of Directors has a fiduciary duty to consider (collectively
        referred to herein as a “Transaction
    Company”) on the terms set forth either in the November 11, 2008 letter
    of interest, or in such other offer received by HCNV (the “Transaction”),
    the maturity of the Notes shall be extended (the “Extension Period”)
    to May 31, 2009 (“Maturity”). No late fees or penalties, other
    than those contemplated herein, will be assessed on HCNV during the Extension
    Period. 

	 	 
	Interest:	
         1%
      percent per month (or part thereof) compound interest applied effective
      as of the first day of each calendar month on the Notes. Interest shall
      be payable in cash at Maturity, however, in the event the Transaction is
      not consummated for any reason, at the election of the Holders interest
      shall be convertible into stock and warrants of HCNV as set forth in the
    Section titled “Conversion”. 

 

 a  Treatment of Bigl's
letter agreement subject to discussion when it has been located.  

	Expenses: 	
           HCNV to
        pay all of Holders' reasonable legal and professional costs incurred
        in connection with the transactions contemplated hereby, which, if the
        Initial Closing occurs on or before December 19, 2008, will not exceed
        an aggregate of $75,000, plus all of Holders' reasonable travel and
        subsistence costs. All such costs shall be paid on the earlier to occur
        of the Initial Closing and December 19, 2008. Any legal and professional
        costs incurred after December 19, 2008 shall not be subject to the foregoing
        limitations. It is contemplated that the Holders party to this Term Sheet
    will select one law firm to act on their behalf in the proposed transaction. 

	 	 
	Maturity: 	      The Notes shall mature on
      either (a) the earlier of (x) May 31, 2009, or (y) the closing of the
      Transaction; or (b) in the event the Transaction does not close by May
      31, 2009, the Notes shall mature on May 30, 2010, subject to the terms
    set forth below.

	 	 
	Conversion: 	
           In
        the event the Transaction does not close by May 31, 2009, at any time
        thereafter the Holders may convert the Notes plus accrued interest into
        HCNV common stock at $0.20 per share. HCNV will covenant to reserve
        and keep available authorized and unissued common stock for purposes
    of conversion of the Notes. 

	 	 
	Warrants 	      HCNV
          shall issue warrants for the Holders to purchase HCNV common stock
          at 100% of the note value, plus interest, exercisable at a price of $0.30
          per share, exercisable in the event the Transaction does not close
          by May 31, 2009. These warrants will include a provision stipulating
          that exercise of the warrants will be subject to HCNV shareholder approval,
          to the extent required, to increase the authorized shares available
          for issuance upon exercise of the warrants. HCNV covenants to ensure
          these warrants are properly issued, and will use its best efforts to
          cause such shareholder approval to be obtained, and, thereafter, to
          reserve and keep available authorized and unissued common stock for
          purposes of exercise of warrants. Prior to obtaining the above-referenced
          shareholder approval, HCNV will not issue common stock, except pursuant
          to conversion of Notes, exercise of the above referenced warrants or
          pursuant to obligations to which HCNV is subject as of the date of
    this Term Sheet. 

	 	 
	Warrant Tenure: 	
           In
        the event warrants become exercisable, they shall be exercisable for
    a period of five years from May 31, 2009.

	 	 
	Anti Dilution: 	
           The
        Holders shall be protected for the period from the date of this term
        sheet through May 31, 2011 by a contractual obligation upon HCNV to reset
        the terms of the Note conversion and the warrant exercise price in the
        event of the issuance of equity at a price lower than the strike price
        of the warrants referred to above based on a “Volume Weighted Average.” Anti-dilution
        protection shall contain exceptions for employee stock option plans and
        other stock based compensation plans in amounts and upon terms to be
    agreed. 

	 	 
	Required Holders: 	
           Most
        amendments and waivers will be subject to a two-thirds majority vote
        of outstanding principal amount of the Notes, with exceptions for certain
        fundamental changes such as extensions, changes in principal and interest,
    and the like, which will require unanimity. 

	 	 
	Basic Terms and 

      Conditions: 	
      

     Consummation
        of the transactions contemplated by this Term Sheet will be subject to
        negotiation, execution and delivery of mutually acceptable definitive
    documentation, which will include the following (non-exhaustive) items: 

	 	 

	 	a)     	 Holders to be repaid in full in cash
    at closing of the Transaction. 

 

	 	
b)     	
     Existing legal agreements and structure to be fully reviewed by Holder’s nominated US attorney, and revised as appropriate.
  
	 
	 	
c)     	
     Holders to have rights to nominate two directors to HCNV’s Board of Directors out of a maximum of 5 directors on the earlier of (i) May 31, 2009, or (ii) the termination of the offer letter from
the Transaction Company. Additionally, during the Extension Period, no director shall be replaced, provided, however, that HCNV shall be permitted to fill any vacancies in the three board seats that are not held by the Holders or their
nominees.
  
	 
	 	
d)     	
     The Holders shall have the right to veto the appointment of the CFO of HCNV until such time as all Notes are either converted or repaid in full. However, the Holders accept the current CFO.
  
	 
	 	
e)     	
     During the Extension Period, HCNV’s Board or management shall not initiate any changes in the CEO, CFO, president and COO without the Required Holders' express approval.
  
	 
	 	
f)     	
     During the Extension Period, HCNV shall not modify existing, or enter into new, management agreements or consulting agreements without the Required Holders' consent. Notwithstanding the foregoing,
HCNV shall not be required to obtain such consent to enter into agreements which are in the ordinary course of HCNV’s business.
  
	 
	 	g)	      HCNV shall provide confirmation that the
      prior Ansley contract for services has been terminated as of June 30th (executed
      August 1, 2008) and that there will be no further retainers and or expenses
      and or fees of any kind payable to any investment bankers except on a success
      fee basis only. The current Engagement Letter with Ansley will be amended
      (executed August 1, 2008) such that any future Placement Fee shall be based
      solely on new monies from sources outside of the Holders and their affiliated
      entities and or the existing investors. HCNV agrees that it will share
      all information with the Holders regarding the mandate to sell the business
    and / or raise new capital. 
	 	 	 
	 	
h)     	
     HCNV shall provide a representation to Holders as to its belief that the financing herein contemplated is adequate to meet the concerns previously expressed by HIP and other key customers of HCNV as
to the adequacy of working capital available to HCNV to fully support HCNV’s current service offerings in support of these HMO’s.
  
	 
	 	
i)     	
     The Holders will provide funding at the Initial Closing to pay off HCNV’s bank indebtedness (approximately $250,000). Immediately upon repayment of the bank indebtedness and filing of
appropriate UCC-3 termination statements or other termination documents, the Holders shall have a first ranking security interest over all the assets of HCNV and each of its subsidiaries.
  
	 
	 	
j)     	
     During the Extension Period, HCNV shall provide the Holders, in a timely manner, all material financial information (the “Information”), subject to HCNV’s legal obligations and the
Holders’ representations that they understand that the Information is not public and that they cannot and will not trade on the Information.
  
	 
	 	
k)     	
     During the Extension Period, HCNV shall report to the Holders non-financial matters including but not limited to major client problems, senior management problems, and contract cancellations, within
four days of their occurrence.
  
	 
	 	
l)     	
     During the Extension Period, there shall be a weekly report to the Holders, either by e-mail or conference call, regarding the Transaction Company project.
  
	 
	 	
m)     	
     In the event that the Transaction is not completed, or if the Notes otherwise come due on May 31, 2009, HCNV shall thereafter pay the Holders a monthly fee of $10,000.
  
	 
	 	
n)     	
     The parties contemplate that all or most of the members of the so-called "Markman" group will agree to an extension of their notes, on terms substantially similar to those
  
	 

	 	 	
contemplated by this Term Sheet. If this does not occur, the parties will attempt to negotiate alternative, mutually satisfactory, arrangements with members of this group.

  
	 
	 	
o)     	
     Such other terms and conditions as the parties may agree to for a transaction of this nature including, without limitation, representations and warranties, affirmative and negative covenants, and
defaults substantially similar to those contained in the August 27, 2008 draft Securities Exchange and Purchase Agreement previously made available to HCNV.
  
	 

	Forbearance: 	     The
          Holders, by executing this Term Sheet, hereby agree to forbear from
          exercising any rights and remedies that may exist under the Notes for
          the period from November 26, 2008 through December 19, 2008 (the “Forbearance
          Period”). HCNV acknowledges and agrees that this Term Sheet is
          not intended to, nor shall it, establish any course of dealing between
          HCNV and the Holders that is inconsistent with the express terms of
          the Notes and the documents related thereto. HCNV acknowledges and
          agrees that (a) this Term Sheet shall not operate as a waiver of any
          right, power or remedy of the Holders under the Notes or other documents
          related thereto, nor shall it constitute a continuing waiver at any
          time, (b) the Holders shall not have any obligation to extend the term
          of the Forbearance Period, (c) nothing herein shall be deemed to constitute
          a waiver of any Default or Event of Default under the Notes or any
          documents related thereto, and nothing herein shall in any way prejudice
          the rights and remedies of the Holders under the Notes, any documents
          related thereto or applicable law. In addition, the Holders shall have
          the right to waive any condition or conditions set forth in this Term
          Sheet, the Notes or any other documents related thereto, in their sole
          discretion, and any such waiver shall not prejudice, waive or reduce
          any other right or remedy that the Holders may have against HCNV. 

            Except
          as expressly provided in the first sentence of the immediately preceding
          paragraph, all provisions of the Notes and the other documents related
    thereto shall remain in full force and effect and be unaffected hereby. 

	 	 
	Termination: 	
           The
        obligations of the Holders hereunder shall terminate on December 19,
        2008, and shall thereafter be of no further force and effect, and
          none of the parties hereto shall have any rights or remedies against
          any other party hereto arising out of or in connection with this Term
    Sheet.

 

 

 

 

                                    Agreed and Accepted: 

HOLDERS: 

	 	 	              HCNV

	 	                  	/s/
    David Chess 
	Welwyn Management Company 	   	
By: David Chess, Chief Executive              
	/s/
    Richard DeLater 	   	
Officer and President  
	
By: Richard DeLater  	   	
Date: November 26, 2008  
	
Date: November 26, 2008  	   	   
	 	 	 
	
Nicholas Barham

/s/ Nicholas Barham	   	   
	
Date: November 26, 2008  	   	   
	 	 	 
	
The Kenneth D Lamé Living Trust          

/s/ Kenneth D Lamé  	   	   
	
By: Kenneth D. Lamé  	   	   
	
Date: November 26, 2008  	   	   
	 	 	 
	
Pacific Aerie Holding LLC

/s/ Jon T. Lamé  	   	   
	
By: Jon T. Lamé, Manager  	   	   
	
Date: November 26, 2008  	   	   
	 	 	 
	
James J. Bigl Revocable Trust

 /s/ James J. Bigl	   	   
	
By: James J. Bigl  	   	   
	
Date: November 26, 2008exh10-3_259862.htm

    EXHIBIT
10.3

     

    CONTRIBUTION
AGREEMENT

     

    THIS
CONTRIBUTION AGREEMENT is made as of this 1st day of December 2008, by and among
CIOC Acquisition Inc., a newly formed Delaware corporation (the “Company”), Nurlan
Janseitov and Timur Bergaliyev.

     

    Recitals

     

    A. Mr.
Janseitov and Mr. Bergaliyev, who collectively hold an approximately 91.6%
ownership interest in Caspian International Oil Corporation, a Delaware
corporation (“Caspian”), expect to
file a Schedule 13E-3 with the Securities and Exchange Commission announcing
their intention to cause the Company to effect a “short-form” merger (the “Merger”) with and
into Caspian under Section 253 of the Delaware General Corporation Law (the
“DGCL”), with
Caspian as the surviving corporation (the “Surviving
Corporation”), pursuant to which (i) the stockholders of Caspian
(other than the Company) will receive cash in exchange for their shares of
Caspian common stock, par value $0.001 per share (the “Caspian Common
Stock”), (ii) Mr. Janseitov and Mr. Bergaliyev will receive shares
of common stock of the Surviving Corporation, and (iii) immediately
following the Merger, Mr. Janseitov and Mr. Bergaliyev will own all equity
interests in the Surviving Corporation.

     

    B. To
effect the Merger, pursuant to the terms and conditions set forth herein, Mr.
Janseitov and Mr. Bergaliyev desire to contribute to the Company, immediately
prior to the consummation of the Merger, all of their respective shares of
Caspian Common Stock, as of such time (the “Effective
Time”).

     

    C.
Following the contribution by Mr. Janseitov and Mr. Bergaliyev of their shares
of Caspian Common Stock pursuant to this Agreement, the Company will hold
approximately 91.6% of the outstanding shares of Caspian Common
Stock.

     

    D. Each
of Mr. Janseitov and Mr. Bergaliyev desire to evidence herein their unanimous
consent to, and approval of, the Merger.

     

    Agreement

     

    NOW
THEREFORE, in consideration of the mutual covenants contained in this Agreement,
the parties hereto agree as follows:

     

    1. Interpretation of this
Agreement.

     

    (a) Terms Defined. As
used in this Agreement, the following terms when used in this Agreement have the
meanings set forth below:

     

    “Agreement” means this
Contribution Agreement and all exhibits and schedules hereto, as amended,
modified or supplemented from time to time.

     

    “Caspian” shall have
the meaning given to it in the preamble of this Agreement.

     

    “Caspian Common Stock”
shall have the meaning given to it in the recitals of this
Agreement.

     

    “Company Common Stock”
means the Company’s common stock, par value $0.01 per share.

     

    “Company” shall have
the meaning given to it in the preamble of this Agreement.

     

    “Contributed Shares”
shall have the meaning given to it in Section 2(a) of
this Agreement.

     

    “DGCL” shall have the
meaning given to it in the recitals of this Agreement.

     

    “Effective Time” shall
have the meaning given to it in the recitals of this Agreement.

     

     “Merger” shall have
the meaning given to it in the recitals to this Agreement.

    
      
        
           

        

         

      

      
        1

        
          

        

      

      
         

      

    

     

    “Person” means an
individual, a partnership, a corporation, a limited liability company, an
association, a joint stock company, a trust, a joint venture, an unincorporated
organization and a governmental entity or any department, agency or political
subdivision thereof.

     

     “Securities Act” means
the Securities Act of 1933, as amended.

     

    “Shares” shall have
the meaning given to it in Section 2(b) of
this Agreement.

     

    “Subsidiary” when used
with respect to any Person means any other Person, whether incorporated or
unincorporated, of which (a) more than 50% of the securities or other
ownership interests or (b) securities or other interests having by their
terms ordinary voting power to elect more than 50% of the board of directors or
others performing similar functions with respect to such corporation or other
organization, is directly owned or controlled by such Person or by any one or
more of its Subsidiaries.

     

    “Surviving
Corporation” shall have the meaning given to it in the recitals to this
Agreement.

     

    (b) Interpretation.
Wherever from the context it appears appropriate, each term stated in either the
singular or plural shall include the singular and the plural, and pronouns
stated in masculine, feminine or neuter gender shall include the masculine,
feminine and the neuter.

     

    2. Contribution of Caspian
Common Stock; Issuance of Shares; Consent to Merger.

     

    (a) Contribution of Caspian
Common Stock. At the Effective Time, Mr. Janseitov and Mr. Bergaliyev
shall contribute, assign and transfer to the Company, and the Company shall
accept, all of the shares of Caspian Common Stock held by Mr. Janseitov and Mr.
Bergaliyev, as set forth opposite Mr. Janseitov and Mr. Bergaliyev’s name on
Exhibit A
hereto (the “Contributed Shares”),
free and clear of all liens, claims, encumbrances and restrictions of any kind
whatsoever plus an amount of cash as set forth opposite Mr. Janseitov and Mr.
Bergaliyev’s name in Exhibit A.

     

    (b) Issuance of Shares.
In consideration for each Mr. Janseitov and Mr. Bergaliyev’s contribution of the
Contributed Shares to the Company pursuant to Section 2(a),
the Company shall issue to each Mr. Janseitov and Mr. Bergaliyev the shares of
Company Common Stock as set forth opposite such Mr. Janseitov and Mr.
Bergaliyev’s name on Exhibit A hereto (the
“Shares”), free
and clear of any liens, claims, encumbrances and restrictions of any kind
whatsoever. Upon the issuance of the Shares, all other outstanding shares of
Company Common Stock will be cancelled.

     

    (c) Consent to the
Merger. Each of Mr. Janseitov and Mr. Bergaliyev, as evidenced by their
signature hereto, in lieu of a special meeting of the stockholders of the
Company, does hereby consent to and approve (i) the Merger, (ii) the
execution, delivery and performance by the Company of a Certificate of Ownership
and Merger, in substantially the form attached hereto as Exhibit B, and
(iii) the other transactions contemplated herein and therein.

     

    (d) Representations and
Warranties of the Company. The Company hereby represents and warrants to
Mr. Janseitov and Mr. Bergaliyev as follows:

     

    (i) Organization; Power and
Authority. The Company is a corporation duly organized, validly existing,
and in good standing under the laws of State of Delaware. The Company has full
corporate power and authority to carry on the business in which it is engaged
and to own and use the properties owned and used by it. Before giving effect to
the transactions contemplated herein, the Company does not have any
Subsidiaries, and does not own, directly or indirectly, any capital stock or
other equity interests in any other Person.

     

    (ii)
Authorization of
Transaction; Agreement Binding. The Company has full corporate power and
authority to execute and deliver, and to perform its obligations under, this
Agreement. This Agreement constitutes the valid and legally binding obligation
of the Company, enforceable in accordance with its terms, except as such
enforcement may be limited by general equitable principles or by applicable
bankruptcy, insolvency or similar laws which affect creditors’ rights
generally.

     

    (iii)
No Conflict.
The execution, delivery and performance of this Agreement by the Company does
not and will not violate, conflict with, or result in a breach of or default
under (A) the Company’s

    
      
        
           

        

         

      

      
        2

        
          

        

      

      
         

      

    

     

    Certificate
of Incorporation or Bylaws; (B) any applicable law, order, judgment or
decree; or (C) any agreement, contract, understanding, mortgage, indenture
or other obligation to which the Company is a party or by which any of its
assets or properties are bound.

     

    (e) Representations and
Warranties of Mr. Janseitov and Mr. Bergaliyev. Each Mr. Janseitov and
Mr. Bergaliyev hereby represents and warrants to the Company as
follows:

     

    (i) Capacity. Such Mr.
Janseitov and Mr. Bergaliyev has full capacity to execute and deliver, and to
perform such Mr. Janseitov and Mr. Bergaliyev’s obligations under, this
Agreement.

     

    (ii)
Agreement
Binding. This Agreement constitutes the valid and legally binding
obligation of such Mr. Janseitov and Mr. Bergaliyev, enforceable in accordance
with its terms.

     

    (iii)
Acquisition for
Investment. Such Mr. Janseitov and Mr. Bergaliyev is acquiring the Shares
for investment solely for such Mr. Janseitov and Mr. Bergaliyev’s account and
not with a view to or for sale in connection with any distribution thereof in
violation of the federal securities laws, applicable state securities laws or
this Agreement.

     

    (iv)
Accredited
Investor. Such Mr. Janseitov and Mr. Bergaliyev is an “accredited
investor” within the meaning of Rule 501 promulgated under the
Securities Act.

     

    (v) Title to Contributed
Shares. Such Mr. Janseitov and Mr. Bergaliyev owns the Contributed Shares
set forth opposite such Mr. Janseitov and Mr. Bergaliyev’s name on Exhibit A hereto,
free and clear of any liens, claims, encumbrances and restrictions of any kind
whatsoever.

     

    3. Termination. This
Agreement and the obligation of Mr. Janseitov and Mr. Bergaliyev to contribute
the Contributed Shares and any cash will terminate automatically and immediately
upon the earliest to occur of (a) the full discharge of the obligations
herein in connection with the Merger and (b) the Merger not being
consummated by July 1, 2009.

     

    4. Severability.
Whenever possible, each provision of this Agreement will be interpreted in such
manner as to be effective and valid under applicable law, but if any provision
of this Agreement is held to be invalid, illegal or unenforceable in any respect
under any applicable law or rule in any jurisdiction, such invalidity,
illegality or unenforceability will not affect any other provision or any other
jurisdiction, but this Agreement will be reformed, construed and enforced in
such jurisdiction as if such invalid, illegal or unenforceable provision had
never been contained in this Agreement.

     

    5. Complete Agreement.
This Agreement embodies the complete agreement and understanding among the
parties and supersedes and preempts any prior understandings, agreements or
representations by or among the parties, written or oral, which may have related
to the subject matter of this Agreement in any way.

     

    6. Counterparts. This
Agreement may be executed on separate counterparts, each of which is deemed to
be an original and all of which taken together constitute one and the same
agreement. Any telecopied signature shall be deemed a manually executed and
delivered original.

     

    7. Successors and
Assigns. This Agreement is intended to bind and inure to the benefit of
and be enforceable by Mr. Janseitov and Mr. Bergaliyev, the Company, and their
respective successors and assigns and, where applicable, heirs and personal
representatives.

     

    8. Choice of Law;
Jurisdiction. This Agreement shall be deemed to be made in and in all
respects shall be interpreted, construed and governed by and in accordance with
the laws of the State of New York without regard to conflicts of law principles
thereof. The parties hereby irrevocably submit to the personal jurisdiction of
the courts of the State of New York located in the Borough of Manhattan, and the
Federal courts of the United States of America located in the State of New York,
Borough of Manhattan, solely in respect of the interpretation and enforcement of
the provisions of this Agreement and of the documents referred to in this
Agreement, and in respect of the transactions contemplated hereby, and hereby
waive, and agree not to assert, as a defense in any action, suit or proceeding
for the interpretation or enforcement hereof or of any such document, that it is
not subject thereto or that such action, suit or proceeding may not be brought
or is not maintainable in said courts or that the venue thereof

    
      
        
           

        

         

      

      
        3

        
          

        

      

      
         

      

    

     

    may not
be appropriate or that this Agreement or any such document may not be enforced
in or by such courts, and the parties hereto irrevocably agree that all claims
with respect to such action or proceeding shall be heard and determined in such
a New York State or Federal court. The parties hereby consent to and grant any
such court jurisdiction over the person of such parties and, to the extent
permitted by law, over the subject matter of such dispute and agree that mailing
of process or other papers in connection with any such action or proceeding in
the manner provided in herein or in such other manner as may be permitted by law
shall be valid and sufficient service thereof.

     

    9. Waiver of Jury Trial.
Each party acknowledges and agrees that any controversy which may arise under
this Agreement is likely to involve complicated and difficult issues, and
therefore each such party hereby irrevocably and unconditionally waives any
right such party may have to a trial by jury in respect of any litigation
directly or indirectly arising out of, under or relating to this Agreement, or
any of the transactions contemplated by this Agreement. Each party certifies and
acknowledges that (i) no representative, agent or attorney of any other
party has represented, expressly or otherwise, that such other party would not,
in the event of litigation, seek to enforce the foregoing waiver, (ii) each
party understands and has considered the implications of this waiver,
(iii) each party makes this waiver voluntarily and (iv) each party has
been induced to enter into this Agreement by, among other things, the mutual
waivers and certifications expressed above.

     

    10. Remedies. Each of the
parties to this Agreement will be entitled to enforce its rights under this
Agreement specifically, to recover damages by reason of any breach of any
provision of this Agreement and to exercise all other rights existing in its
favor. The parties hereto agree and acknowledge that money damages may not be an
adequate remedy for any breach of the provisions of this Agreement and that any
party may in its sole discretion apply to any court of law or equity of
competent jurisdiction for specific performance and/or injunctive relief in
order to enforce or prevent any violations of the provisions of this
Agreement.

     

    11. Amendments and
Waivers. No provision of this Agreement may be amended or waived without
the prior written consent or agreement of Mr. Janseitov, Mr. Bergaliyev and the
Company.

     

    12. Business Days.
Whenever the terms of this Agreement call for the performance of a specific act
on a specified date, which date falls on a Saturday, Sunday or legal holiday,
the date for the performance of such act shall be postponed to the next
succeeding regular business day following such Saturday, Sunday or legal
holiday.

     

    13. No Third Party
Beneficiary. Except for the parties to this Agreement and their
respective successors and assigns, nothing expressed or implied in this
Agreement is intended, or will be construed, to confer upon or give any person
other than the parties hereto and their respective successors and assigns any
rights or remedies under or by reason of this Agreement.

     

    [SIGNATURES
BEGIN ON THE FOLLOWING PAGE]

     

    
      
        
           

        

         

      

      
        4

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, intending to be legally bound hereby, each of the undersigned
has duly executed and delivered this Contribution Agreement as of the day and
year first above written.

     

    
      
        
          
            
              
                
                  
                    
                      	 	 
      	 
      	 
      
	 	
                              CIOC
      ACQUISITION INC.

                            
	 	 
      	 
      
	 	
                              By:

                            	 
      	
                              
                                /s/
      Thomas C. Sima

                              

                            
	 	
                              Name:

                            	 
      	
                              Thomas
      C. Sima

                            
	 	
                              Title:

                            	 
      	
                              Secretary

                            
	 	 
      	 
      
	 	
                              Address:

                            	 
      	
                              c/oEisenberg
      & Sima LLP

                            
	 	 
      	 
      	
                              350
      Fifth Avenue, Suite 6708

                              New
      York, NY  10118

                            
	 	 
	 	 
      
	 	
                              NURLAN
      JANSEITOV

                            
	 	 
      	 
      
	 	
                              By:

                            	 
      	
                              
                                /s/
      Nurlan Janseitov

                              

                            
	 	
                              Name:

                            	 
      	
                              Nurlan
      Janseitov

                            
	 	 
      	 
      
	 	
                              Address:

                            	 
      	
                              House
      4, Novaya Street, Koktyube-2

                              Almaty,
      050000 Kazakhstan

                            
	 	 
      	 
      	 
      
	 	 
	 	 
      
	 	
                              TIMUR
      BERGALIYEV

                            
	 	 
      	 
      
	 	
                              By:

                            	 
      	
                              
                                /s/
      Timur Bergaliyev

                              

                            
	 	
                              Name:

                            	 
      	
                              Timur
      Bergaliyev

                            
	 	 
      	 
      
	 	
                              Address:

                            	 
      	
                              10B
      Abay Street, Apt. 9

                              Almaty,
      050000 Kazakhstan

                            
	 	 
      	 
      	 
      
	 	 
      	 
      	 
      

                    

                  

                

              

            

          

        

      

    

     

    
      
        
           

        

         

      

      
        5

        
          

        

      

      
         

      

    

    

    Exhibit
A

     

    
      
        
          
            
              
                
                  
                    
                      	 
      	
                                

                            	
                              Contributed Shares

                            	 	
                                Cash

                            	 	
                              Shares

                            
	
                              Nurlan
      Janseitov

                            	
                                

                            	
                              28,990,000

                            	 	
                              $0.00

                            	 	
                              50.416

                            
	 	 	 	 	 	 	 
	
                              Timur
      Bergaliyev

                            	
                                

                            	
                              28,511,500

                            	 	
                              $0.00

                            	 	
                              49.584

                            

                    

                  

                

              

            

          

        

      

    

     

     

     

    

    
      
        
           

        

         

      

      
        6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00150-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00150-of-00352.parquet"}]]